HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yue Han Selected Research

proctolin

2/2022A proctolin-like peptide is regulated after baculovirus infection and mediates in caterpillar locomotion and digestion.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yue Han Research Topics

Disease

52Neoplasms (Cancer)
03/2022 - 08/2004
33Infections
04/2022 - 02/2009
17Graft vs Host Disease (Graft-Versus-Host Disease)
06/2022 - 08/2006
17Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022 - 01/2011
17Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 06/2014
13Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2022 - 02/2009
12Myelodysplastic Syndromes (Myelodysplastic Syndrome)
06/2022 - 06/2013
11Aplastic Anemia (Anemia, Hypoplastic)
01/2022 - 11/2014
11Neoplasm Metastasis (Metastasis)
01/2022 - 07/2015
10Hemorrhage
02/2022 - 11/2014
9Thrombosis (Thrombus)
10/2022 - 10/2009
9Thrombocytopenia (Thrombopenia)
12/2021 - 05/2015
8Inflammation (Inflammations)
10/2022 - 11/2011
8Hepatocellular Carcinoma (Hepatoma)
10/2021 - 12/2016
8Chronic Hepatitis B
10/2021 - 09/2007
7Sepsis (Septicemia)
01/2022 - 10/2016
7Leukemia
09/2021 - 01/2011
6Thrombotic Microangiopathies
06/2022 - 11/2017
6Port-Wine Stain (Nevus Flammeus)
03/2022 - 03/2019
6Hematologic Neoplasms (Hematological Malignancy)
02/2022 - 10/2009
6Disseminated Intravascular Coagulation
12/2021 - 08/2012
6Residual Neoplasm
09/2021 - 11/2011
6Hypertension (High Blood Pressure)
01/2021 - 07/2013
5Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
01/2022 - 06/2001
5Hepatitis B
01/2022 - 01/2017
5Acute Promyelocytic Leukemia
12/2021 - 08/2012
5Ovarian Neoplasms (Ovarian Cancer)
04/2021 - 11/2013
4Hypoxia (Hypoxemia)
10/2022 - 12/2016
4Heart Failure
01/2022 - 01/2018
4Acute Kidney Injury (Acute Renal Failure)
01/2022 - 07/2016
4Vascular Remodeling
01/2021 - 02/2011
4Carcinogenesis
01/2021 - 04/2015
3Critical Illness (Critically Ill)
01/2022 - 07/2016
3Hyperplasia
01/2022 - 08/2004
3Philadelphia Chromosome
01/2021 - 10/2013
3Autoimmune Diseases (Autoimmune Disease)
01/2021 - 03/2013
3Disease Progression
01/2020 - 12/2011
3Bacterial Infections (Bacterial Infection)
12/2019 - 11/2017
3Liver Neoplasms (Liver Cancer)
07/2016 - 04/2012
3Mumps
03/2016 - 01/2011
3Thrombotic Thrombocytopenic Purpura
08/2014 - 09/2012

Drug/Important Bio-Agent (IBA)

14Proteins (Proteins, Gene)FDA Link
01/2022 - 05/2002
12Long Noncoding RNAIBA
07/2021 - 10/2017
12VaccinesIBA
04/2021 - 05/2006
11Pharmaceutical PreparationsIBA
01/2022 - 01/2017
10DecitabineFDA Link
01/2021 - 06/2013
9Biomarkers (Surrogate Marker)IBA
01/2022 - 09/2007
8AntigensIBA
01/2022 - 08/2006
7DNA (Deoxyribonucleic Acid)IBA
01/2022 - 01/2013
7NucleotidesIBA
10/2021 - 01/2011
6Small Interfering RNA (siRNA)IBA
01/2022 - 01/2017
6Dacarbazine (DIC)FDA LinkGeneric
12/2021 - 04/2005
5RNA (Ribonucleic Acid)IBA
01/2022 - 04/2015
5Hepatitis B Surface Antigens (HBsAg)FDA Link
01/2022 - 01/2013
5Inosine Triphosphate (ITP)IBA
01/2022 - 06/2001
4Hemostatics (Antihemorrhagics)IBA
10/2022 - 08/2012
4Peptides (Polypeptides)IBA
02/2022 - 11/2011
4Chimeric Antigen ReceptorsIBA
02/2022 - 01/2019
4Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA
12/2021 - 01/2020
4Hepatitis B e AntigensIBA
10/2021 - 08/2013
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2021 - 06/2015
4Cisplatin (Platino)FDA LinkGeneric
02/2021 - 11/2013
4HDL LipoproteinsIBA
01/2021 - 10/2015
4Untranslated RNA (Noncoding RNA)IBA
01/2021 - 10/2017
4Biological ProductsIBA
01/2021 - 01/2011
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2022 - 08/2004
3ThrombinFDA Link
01/2022 - 08/2014
3Surface Antigens (Surface Antigen)IBA
01/2022 - 12/2011
3Sorafenib (BAY 43-9006)FDA Link
05/2021 - 12/2016
3Antiviral Agents (Antivirals)IBA
05/2021 - 12/2013
3BilirubinIBA
05/2021 - 07/2017
3O Antigens (O Antigen)IBA
03/2021 - 11/2017
3AcidsIBA
12/2020 - 09/2012
3IntegrinsIBA
07/2020 - 09/2017
3Rituximab (Mabthera)FDA Link
01/2020 - 09/2017
3entecavirFDA Link
01/2020 - 08/2013
3Methotrexate (Mexate)FDA LinkGeneric
01/2019 - 02/2009
3LipidsIBA
01/2019 - 12/2014
3Polysaccharides (Glycans)IBA
01/2018 - 11/2017
3recombinant FVIIa (rFVIIa)FDA Link
12/2017 - 02/2015
3Indicators and Reagents (Reagents)IBA
12/2016 - 05/2010
3Cyclosporine (Ciclosporin)FDA LinkGeneric
11/2014 - 08/2006
3thiamine triphosphorate (TTP)IBA
08/2014 - 07/2011
3CytokinesIBA
05/2014 - 08/2004

Therapy/Procedure

46Hematopoietic Stem Cell Transplantation
06/2022 - 08/2006
42Therapeutics
06/2022 - 05/2002
25Transplantation
06/2022 - 02/2009
14Drug Therapy (Chemotherapy)
01/2022 - 01/2011
12Stem Cell Transplantation
01/2022 - 01/2016
6Cell Transplantation
12/2021 - 10/2013
5Immunotherapy
01/2021 - 12/2018
5Radiofrequency Ablation
01/2019 - 04/2012
4Photochemotherapy (Photodynamic Therapy)
03/2022 - 06/2019
4Induction Chemotherapy
08/2019 - 11/2011
3Punctures
01/2022 - 04/2012
3Length of Stay
12/2021 - 01/2019
3Ligation
03/2021 - 01/2018
3Dye Lasers
04/2020 - 03/2019
3Radiotherapy
01/2018 - 01/2015
3Aftercare (After-Treatment)
12/2014 - 08/2012